banner Khondrion vs 3

Khondrion announces that the first patients have been successfully dosed in its KHENEREXT Phase IIb open-label extension study

Khondrion, a clinical-stage biopharmaceutical company discovering and developing therapies targeting primary mitochondrial diseases, today announces that the first patients have been successfully dosed.

Read more


NXP Reichswald MTB tour

Every year in autumn, NXP Cycletime organizes the Reichswald MTB tour.

Read more

Subscribe to the NTC Newsletter


// Health tech in the move

INNOVATE // Rikus Wolbers

During the Innovate Meetup, Rikus elaborated on Novio Tech Campus. About the campus as a unique open innovation environment and the Nijmegen offer to innovators in Health and High Tech.

RTL Z // Nexperia

Nexperia is a global player in the area of discrete, logic and MOSFET-components. They produce around 100 billion a year. RTL Z came to Nijmegen to talk to them.

Settle at Novio Tech Campus!

Connect with Novio Tech Campus!